share_log

Update: Summit Therapeutics Closes Phase 3 Lung Cancer Study Enrollment, Gets FDA Fast Track; Shares up Premarket

Update: Summit Therapeutics Closes Phase 3 Lung Cancer Study Enrollment, Gets FDA Fast Track; Shares up Premarket

更新:峯會生物關閉第3期肺癌研究招募,獲FDA快速通道;盤前股價上漲
MT Newswires ·  10/04 05:03

Unity Software(U.US) reported fourth-quarter financial results after the market close on Monday. Here's a rundown of the report.Q4 Earnings: Unity said fourth-quarter revenue increased 35% year-over-year to $609 million, beating the consensus estimate of $562.71 million. The company reported a quarterly loss of 66 cents per share.

声明:本內容僅用作提供資訊及教育之目的,不構成對任何特定投資或投資策略的推薦或認可。 更多信息
    搶先評論